NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect. (Q38918211)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect. |
scientific article |
Statements
NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect (English)
Toshiki Etani
Takayoshi Suzuki
Taku Naiki
Ryosuke Ando
Keitaro Iida
Noriyasu Kawai
Keiichi Tozawa
Naoki Miyata
Kenjiro Kohri
Satoru Takahashi
1 February 2015